Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
969-972
Author(s):
Hideyuki Hyogo and Sho-ichi Yamagishi
The Role of AGEs in Cardiovascular Disease
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
979-986
Author(s):
Karin Jandeleit-Dahm and Mark E. Cooper
Advanced Glycation End Products and Insulin Resistance
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
987-989
Author(s):
Hiroyuki Unoki and Sho-ichi Yamagishi
Carbonyl-Scavenging Drugs & Protection Against Carbonyl Stress-Associated Cell Injury
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
8
Page:
319-330
Author(s):
P. C. Burcham, L. M. Kaminskas, D. Tan and S. M. Pyke
Editorial [ Has the Time Come for a New Definition of Microalbuminuria? ]
Journal:
Current Vascular Pharmacology
Volume:
6
Page:
81-83
Author(s):
Asterios Karagiannis, Dimitri P. Mikhailidis, Konstantinos Tziomalos, Anna I. Kakafika and Vasilios G. Athyros
Atherogenesis in Renal Patients: A Model of Vascular Disease?
Journal:
Current Vascular Pharmacology
Volume:
6
Page:
93-107
Author(s):
Georgios Efstratiadis, Konstantinos Tziomalos, Dimitri P. Mikhailidis, Vasilios G. Athyros and Apostolos Hatzitolios
Clinical Proteomics in Application to Predictive Diagnostics and Personalized Treatment of Diabetic Patients
Journal:
Current Proteomics
Volume:
5
Page:
35-44
Author(s):
Olga Golubnitschaja
Flow Cytometry Study of Leukocyte Function: Analytical Comparison of Methods and their Applicability to Clinical Research
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
596-603
Author(s):
E. Matteucci and O. Giampietro
Adiponectin and its Role in Cardiovascular Diseases
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
8
Page:
7-46
Author(s):
Jerzy Beltowski, Anna Jamroz-Wisniewska and Sylwia Widomska
Animal Models of Diabetes Mellitus: Relevance to Vascular Complications
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
309-324
Author(s):
Cecil S. Thompson